Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Branko Cuglievan

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Ejhaem|July 18, 2022
Central nervous system Langerhans cell histiocytosis and neurodegenerative syndrome responding to MEK inhibitionAndrew Wahba, Branko Cuglievan
Nature Reviews. Clinical Oncology|January 27, 2025
Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncologyBranko Cuglievan, Vivek Subbiah
Pediatrics in Review|January 31, 2025
Pediatric Lymphomas: Key Concepts and Clinical Approaches for PediatriciansSamanta Catueno, Branko Cuglievan
Nature Reviews. Drug Discovery|May 29, 2026
Closing the paediatric gap in cancer drug development: a call to industryVivek Subbiah, Branko Cuglievan
Pediatric Blood & Cancer|March 19, 2025
Acute Leukemia in the Crosshairs: First-in-Class Menin Inhibitor Approval for Adults and ChildrenJoanna S Yi, Branko Cuglievan
Blood|February 18, 2017
Kikuchi-Fujimoto diseaseBranko Cuglievan, Roberto N Miranda
Haematologica|September 2, 2016
Aplastic anemia: the correct nomenclature mattersBranko Cuglievan, April DePombo, Guillermo De Angulo
Translational Pediatrics|March 8, 2024
The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 StudySamanta Catueno, Fadi G Haddad, Branko Cuglievan
Acta Haematologica|March 13, 2026
Reconsidering Asparaginase in Leukemia TherapyMaria Frost, Vivek Subbiah, Branko Cuglievan, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2017
Successful conservative treatment of myocardial infarction in a teenager with MTHFR mutationSubhrajit Lahiri, Branko Cuglievan, Jeremy Landeo Gutierrez, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Ejhaem|July 18, 2022
Central nervous system Langerhans cell histiocytosis and neurodegenerative syndrome responding to MEK inhibitionAndrew Wahba, Branko Cuglievan
Nature Reviews. Clinical Oncology|January 27, 2025
Transforming paediatric AML trials: from failing one-size-fits-all methods to precision oncologyBranko Cuglievan, Vivek Subbiah
Pediatrics in Review|January 31, 2025
Pediatric Lymphomas: Key Concepts and Clinical Approaches for PediatriciansSamanta Catueno, Branko Cuglievan
Nature Reviews. Drug Discovery|May 29, 2026
Closing the paediatric gap in cancer drug development: a call to industryVivek Subbiah, Branko Cuglievan
Pediatric Blood & Cancer|March 19, 2025
Acute Leukemia in the Crosshairs: First-in-Class Menin Inhibitor Approval for Adults and ChildrenJoanna S Yi, Branko Cuglievan
Blood|February 18, 2017
Kikuchi-Fujimoto diseaseBranko Cuglievan, Roberto N Miranda
Haematologica|September 2, 2016
Aplastic anemia: the correct nomenclature mattersBranko Cuglievan, April DePombo, Guillermo De Angulo
Translational Pediatrics|March 8, 2024
The efficacy of homoharringtonine in pediatric acute myeloid leukemia: findings from the Chinese Children's Leukemia Group-AML 2015 StudySamanta Catueno, Fadi G Haddad, Branko Cuglievan
Acta Haematologica|March 13, 2026
Reconsidering Asparaginase in Leukemia TherapyMaria Frost, Vivek Subbiah, Branko Cuglievan, et al.
International Journal of Cardiology. Heart & Vasculature|June 16, 2017
Successful conservative treatment of myocardial infarction in a teenager with MTHFR mutationSubhrajit Lahiri, Branko Cuglievan, Jeremy Landeo Gutierrez, et al.
Pageof 12